Art
J-GLOBAL ID:201902278704000803   Reference number:19A2899148

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

一般化重症筋無力症の日本人患者におけるエクリズマブの長期有効性と安全性:Regainオープンラベル延長研究のサブグループ分析【JST・京大機械翻訳】
Author (11):
Material:
Volume: 407  Page: Null  Publication year: 2019 
JST Material Number: A1131A  ISSN: 0022-510X  Document type: Article
Article type: 原著論文  Country of issue: Netherlands (NLD)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
The terminal complement inhibi...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2899148&from=J-GLOBAL&jstjournalNo=A1131A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Genetic variation  ,  Congenital diseases,deformities in general. 

Return to Previous Page